Richard Chin's Net Worth

$23.2 Million

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is Richard Chin?

Richard Chin has an estimated net worth of $23.2 Million. This is based on reported shares across multiple companies, which include Kindred Biosciences, Inc., RXI PHARMACEUTICALS CORP, OXIGENE INC, and ImmunoCellular Therapeutics, Ltd..

SEC CIK

Richard Chin's CIK is 0001337252

Past Insider Trading and Trends

2006 was Richard Chin's most active year for acquiring shares with 15 total transactions. Richard Chin's most active month to acquire stocks was the month of December. 2021 was Richard Chin's most active year for disposing of shares, totalling 21 transactions. Richard Chin's most active month to dispose stocks was the month of December. 2014 saw Richard Chin paying a total of $354,875.00 for 641,731 shares, this is the most they've acquired in one year. In 2021 Richard Chin cashed out on 4,886,930 shares for a total of $24,949,312.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kindred Biosciences, Inc. No price found

Chief Executive Officer

Richard Chin used to own units in Common Stock but no longer holds any shares there.acquired a total of 275,000 shares in Kindred Biosciences, Inc., Richard also disposed a total of 3,073,546 shares of Kindred Biosciences, Inc. equalling to $22,550,828.64.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.72M
$9.25
-$15,884,756.75
0
Aug 27
Form 4
-19.00%
-360.00K
$9.21
-$368,240.00
1.53M
Scheduled
Jul 22 - Aug 2
Form 4
-2.07%
-40.00K
$9.18
-$367,080.00
1.89M
Scheduled
Jul 2
Form 4
-2.03%
-40.00K
$9.18
-$367,268.00
1.93M
Scheduled
Jun 16
Form 4
+0.30%
5.92K
$5.00
-$32,910.00
1.97M
Feb 1
Form 4
+0.23%
4.59K
$4.93
-$162,231.51
1.97M
Jan 22 - Jan 23
Form 4
+0.84%
16.37K
$4.95
-$104,583.60
1.96M
Jan 17 - Jan 20
Form 4
+0.42%
8.18K
$9.22
-$39,802.74
1.95M
Feb 11
Form 4
+0.90%
17.25K
$9.79
-$198,187.86
1.94M
Jan 22 - Jan 23
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Feb 1
Form 4
+0.83%
15.89K
$10.05
-$217,220.63
1.92M
Jan 22 - Jan 23
Form 4
-2.06%
-40.00K
$10.57
-$422,716.00
1.91M
Scheduled
Jan 2
Form 4
-2.01%
-40.00K
$13.28
-$531,200.00
1.95M
Scheduled
Dec 3
Form 4
-1.97%
-40.00K
$14.68
-$587,200.00
1.99M
Scheduled
Nov 1
Form 4
-1.94%
-40.00K
$13.28
-$531,200.00
2.03M
Scheduled
Oct 1
Form 4
-1.90%
-40.00K
$14.79
-$591,488.00
2.07M
Scheduled
Sep 4 - Sep 5
Form 4
-1.86%
-40.00K
$13.51
-$540,400.00
2.11M
Scheduled
Aug 1
Form 4
-1.83%
-40.00K
$10.28
-$411,200.00
2.15M
Scheduled
Jul 2
Form 4
-2.35%
-52.61K
$10.10
-$531,300.00
2.19M
Scheduled
May 30 - Jun 1
Form 4
-0.14%
-3.06K
$10.00
-$30,600.00
2.24M
Scheduled
May 24 - May 25
Form 4
-0.11%
-2.40K
$10.00
-$24,000.00
2.24M
Scheduled
May 18
Form 4
-0.09%
-1.93K
$10.01
-$19,317.30
2.24M
Scheduled
May 7 - May 9
Form 4
-0.88%
-20.00K
$9.05
-$181,000.00
2.25M
Scheduled
May 1
Form 4
-0.87%
-20.00K
$8.39
-$167,800.00
2.27M
Scheduled
Apr 2
Form 4
-0.50%
-11.47K
$9.15
-$104,996.25
2.29M
Jan 22 - Jan 23
Form 4
-0.56%
-13.00K
$8.26
-$107,380.00
2.3M
Scheduled
Jul 3
Form 4
-0.56%
-13.00K
$7.75
-$100,750.00
2.31M
Scheduled
Jun 22
Form 4
-11.43%
-300.00K
—
—
2.32M
May 17 - Jan 23
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Feb 5
Form 4
—
0
—
—
0
Feb 4
Form 3
—
0
—
—
0
No matching records found

RXI PHARMACEUTICALS CORP (SLS) Snapshot price: $1.16

Investor

Richard Chin owns 31,339 units of Common Stock which is worth $36,353.24. In the year 2009 Richard Chin filed a total of 18 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+68.21%
12.71K
$0.38
$4,829.04
31.34K
Oct 10
Form 4
+76.98%
8.1K
$0.59
$4,781.36
18.63K
Jun 8 - Jul 6
Form 4
+335.00%
8.11K
$0.59
$4,783.13
10.53K
Apr 10
Form 4
∞
2.42K
$1.98
$4,791.60
2.42K
Jan 20
Form 4
—
0
—
—
0
Jul 14
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
$2.96
-$514,812.50
0
Feb 12
Form 4
—
0
$3.17
-$361,505.00
0
Jan 30
Form 4
—
0
—
—
0
Nov 26
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Sep 27
Form 4
—
0
—
—
0
Mar 25
Form 4
—
0
—
—
0
Jan 13
Form 4
—
0
—
—
0
Jan 14
Form 4/A
—
0
—
—
0
Apr 23
Form 4
—
0
—
—
0
Apr 23
Form 3
—
0
—
—
0
No matching records found

OXIGENE INC (OTLC) Snapshot price: $0.02296

President and CEO

Richard Chin owns 392,074 units of Common Stock which is worth $9,002.02. In the year 2005 Richard Chin filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.30%
36.61K
—
—
392.07K
Jan 11
Form 4
+237.05%
250K
—
—
355.46K
Jan 2
Form 4
+75.77%
45.46K
$4.09
$185,837.49
105.46K
Sep 15
Form 4
+50.00%
20K
$3.30
$65,949.67
60K
Aug 1
Form 4
—
0
—
—
0
Jul 6
Form 4
∞
40K
—
—
40K
Aug 24
Form 3
—
0
—
—
0
No matching records found

ImmunoCellular Therapeutics, Ltd. (IMUC) Snapshot price: $0.169

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Sep 20
Form 4
—
0
—
—
0
Aug 2 - Sep 24
Form 3
—
0
—
—
0
No matching records found